Bank Pictet & Cie (Asia) LTD Sop Hi A Genetics Sa Transaction History
Bank Pictet & Cie (Asia) LTD
- $1.57 Trillion
- Q2 2024
A detailed history of Bank Pictet & Cie (Asia) LTD transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Bank Pictet & Cie (Asia) LTD holds 46,020 shares of SOPH stock, worth $144,502. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,020
Previous 46,020
-0.0%
Holding current value
$144,502
Previous $227 Million
7.1%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding SOPH
# of Institutions
36Shares Held
24.6MCall Options Held
500Put Options Held
3.8K-
Ubs Asset Management Americas Inc Chicago, IL7.63MShares$24 Million0.01% of portfolio
-
Generation Investment Management LLP London, X06.79MShares$21.3 Million0.14% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va2.24MShares$7.03 Million0.08% of portfolio
-
Banque Pictet & Cie Sa2.21MShares$6.93 Million0.05% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$6.81 Million0.01% of portfolio
About SOPHiA GENETICS SA
- Ticker SOPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 64,153,700
- Market Cap $201M
- Description
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...